CATABASIS PHARMACEUTICALS INC (18) | Severance Agreements (2)
- Amended and Restated Executive Severance Benefits Plan effective October 7, 2020 (Filed With SEC on May 12, 2022)
- Catabasis Pharmaceuticals, Inc. Amended and Restated Executive Severance Benefits Plan, effective October 7, 2020 (Filed With SEC on November 12, 2020)
